Patents by Inventor Shoen Kume

Shoen Kume has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11692173
    Abstract: The present invention provides, in order to prepare matured hepatocytes analogous in various points to primary hepatocytes, a method for preparing hepatocytes or cells that can be differentiated into hepatocytes from pluripotent stem cells, comprising the steps of: (1) culturing the pluripotent stem cells in a medium containing an activator of an activin receptor-like kinase-4,7; (2) culturing the cells obtained in the step (1) in a medium containing a bone morphogenetic factor and a fibroblast growth factor; (3) culturing the cells obtained in the step (2) in a medium containing an activator of a hepatocyte growth factor receptor and an activator of an oncostatin M receptor; and (4) culturing the cells obtained in the step (3) to obtain hepatocytes or cells that can be differentiated into hepatocytes, wherein in at least one of the steps (2), (3) and (4), cells are cultured on a high-density collagen gel membrane.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: July 4, 2023
    Assignees: TOKYO INSTITUTE OF TECHNOLOGY, KANTO KAGAKU KABUSHIKI KAISHA, CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Shoen Kume, Nobuaki Shiraki, Hiroyuki Yamaguchi, Tomoaki Inoue, Toshito Nakagawa, Jumpei Kiyokawa
  • Publication number: 20220339260
    Abstract: As an approach of efficiently inducing differentiation from pluripotent stem cells into insulin-producing cells, provided is a method comprising the step of three-dimensionally culturing cells in a medium containing a dihydroindolizinone derivative.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 27, 2022
    Applicants: TOKYO INSTITUTE OF TECHNOLOGY, DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Shoen Kume, Nobuaki Shiraki, Tatsuya Yano, Toshihiro Kiho
  • Publication number: 20210340500
    Abstract: As a method for producing enterocytes derived from pluripotent stem cells and having functions corresponding to those of actual enterocytes, a method for producing enterocytes using an enterocyte differentiation medium containing a GSK3 inhibitor, and at least one selected from the group consisting of an activator of a hepatocyte growth factor receptor, an adrenal cortex hormone, calcitriol, and dimethyl sulfoxide is provided.
    Type: Application
    Filed: September 9, 2019
    Publication date: November 4, 2021
    Applicants: TOKYO INSTITUTE OF TECHNOLOGY, THE UNIVERSITY OF TOKYO, KANTO KAGAKU KABUSHIKI KAISHA
    Inventors: Shoen KUME, Nobuaki SHIRAKI, Kazuya MAEDA, Hiroyuki KUSUHARA, Masaya ISHIKAWA, Teruhiko WATANABE
  • Publication number: 20210207085
    Abstract: The present invention provides, in order to prepare matured hepatocytes analogous in various points to primary hepatocytes, a method for preparing hepatocytes or cells that can be differentiated into hepatocytes from pluripotent stem cells, comprising the steps of: (1) culturing the pluripotent stem cells in a medium containing an activator of an activin receptor-like kinase-4,7; (2) culturing the cells obtained in the step (1) in a medium containing a bone morphogenetic factor and a fibroblast growth factor; (3) culturing the cells obtained in the step (2) in a medium containing an activator of a hepatocyte growth factor receptor and an activator of an oncostatin M receptor; and (4) culturing the cells obtained in the step (3) to obtain hepatocytes or cells that can be differentiated into hepatocytes, wherein in at least one of the steps (2), (3) and (4), cells are cultured on a high-density collagen gel membrane.
    Type: Application
    Filed: October 9, 2018
    Publication date: July 8, 2021
    Applicants: TOKYO INSTITUTE OF TECHNOLOGY, KANTO KAGAKU KABUSHIKI KAISHA, CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Shoen KUME, Nobuaki SHIRAKI, Hiroyuki YAMAGUCHI, Tomoaki INOUE, Toshito NAKAGAWA, Jumpei KIYOKAWA
  • Publication number: 20210115397
    Abstract: In order to improve the efficiency of inducing differentiation of pluripotent stem cells, provided is a method for promoting differentiation of pluripotent stem cells, the method including a step of culturing pluripotent stem cells in a medium, wherein the medium is a medium containing a) an insulin-like growth factor, b) an insulin analogue preparation containing no zinc, c) an insulin analogue preparation containing a low concentration of zinc, or d) a compound exhibiting an insulin-like action.
    Type: Application
    Filed: April 25, 2019
    Publication date: April 22, 2021
    Applicants: TOKYO INSTITUTE OF TECHNOLOGY, Ajinomoto Co., Inc.
    Inventors: Shoen KUME, Nobuaki SHIRAKI, Akira CHIBA, Takayuki ENOMOTO
  • Patent number: 10457916
    Abstract: It is an object of the present invention to provide a method for efficiently directing differentiation into insulin-producing cells in a xeno-free culture system.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: October 29, 2019
    Assignee: Tokyo Institute of Technology
    Inventors: Shoen Kume, Nobuaki Shiraki
  • Patent number: 10000739
    Abstract: The purpose of the present invention is to provide a method and a culture medium which are capable of efficiently inducing the differentiation of pluripotent stem cells such as ES cells and iPS cells into desired cells by a simple means. The differentiation of pluripotent stem cells can be induced by culturing mammal-derived pluripotent stem cells in a differentiation culture medium that does not contain at least one amino acid selected from the group consisting of methionine, leucine, cysteine, tyrosine and arginine. Also provided is a differentiation-inducing culture medium which does not contain at least one amino acid selected from the group consisting of methionine, leucine, cysteine, tyrosine and arginine.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: June 19, 2018
    Assignee: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
    Inventors: Shoen Kume, Fumio Endo, Nobuaki Shiraki, Yasuko Shiraki, Kazuhiko Kume
  • Patent number: 9617517
    Abstract: A purpose of the present invention is to provide a small chemical compound which especially promotes induction of the differentiation of ES cells into insulin-producing cells. Another purpose of the present invention is to provide: a method for inducing the differentiation of ES cells into insulin-producing cells using the compound; and an agent for promoting induction of the differentiation into insulin-producing cells. Another purpose of the present invention is to provide the thus-induced insulin-producing cells. Provided are: an agent for promoting induction of the differentiation of stem cells derived from a mammal into insulin-producing cells, which contains a compound that is selected from the group consisting of dopamine metabolism inhibitors, serotonin metabolism inhibitors, acetylchotine, acetylcholine degrading enzyme inhibitors and acetylcholine receptor activators; and a method for inducing differentiation using the agent for promoting induction of differentiation.
    Type: Grant
    Filed: May 1, 2012
    Date of Patent: April 11, 2017
    Assignees: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY, KYOTO UNIVERSITY
    Inventors: Shoen Kume, Daisuke Sakano, Nobuaki Shiraki, Kahoko Umeda, Taiji Yamazoe, Kazuhiko Kume, Motonari Uesugi
  • Publication number: 20170081639
    Abstract: It is an object of the present invention to provide a method for efficiently directing differentiation into insulin-producing cells in a xeno-free culture system.
    Type: Application
    Filed: May 19, 2015
    Publication date: March 23, 2017
    Applicant: TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Shoen KUME, Nobuaki SHIRAKI
  • Patent number: 9376665
    Abstract: An object of the present invention is to provide a method of producing intestinal cells by use of pluripotent stem cells as a starting material. According to the present invention, provided is a method of producing intestinal cells, comprising the steps of: (A) inducing differentiation of pluripotent stem cells into definitive endoderm cells; and (B) culturing the definitive endoderm cells in the presence of (2?Z,3?E)-6-bromoindirubin-3?-oxime (BIO) and N-[(3,5-difluorophenyl)acetyl]-L-Ala-2-phenyl-L-Gly-tert-butyl-OH (DAPT) to thereby induce differentiation of the definitive endoderm cells into intestinal cells.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: June 28, 2016
    Assignees: National University Corporation Kumamoto University, LSIP, LLC
    Inventors: Shoen Kume, Soichiro Ogaki, Nobuaki Shiraki, Kazuhiko Kume
  • Publication number: 20140256043
    Abstract: A purpose of the present invention is to provide a small chemical compound which especially promotes induction of the differentiation of ES cells into insulin-producing cells. Another purpose of the present invention is to provide: a method for inducing the differentiation of ES cells into insulin-producing cells using the compound; and an agent for promoting induction of the differentiation into insulin-producing cells. Another purpose of the present invention is to provide the thus-induced insulin-producing cells. Provided are: an agent for promoting induction of the differentiation of stem cells derived from a mammal into insulin-producing cells, which contains a compound that is selected from the group consisting of dopamine metabolism inhibitors, serotonin metabolism inhibitors, acetylchotine, acetylcholine degrading enzyme inhibitors and acetylcholine receptor activators; and a method for inducing differentiation using the agent for promoting induction of differentiation.
    Type: Application
    Filed: May 1, 2012
    Publication date: September 11, 2014
    Applicants: Kyoto University, National University Corporation Kumamoto University
    Inventors: Shoen Kume, Daisuke Sakano, Nobuaki Shiraki, Kahoko Umeda, Taiji Yamazoe, Kazuhiko Kume, Motonari Uesugi
  • Publication number: 20140199700
    Abstract: An object of the present invention is to provide a method of producing intestinal cells by use of pluripotent stem cells as a starting material. According to the present invention, provided is a method of producing intestinal cells, comprising the steps of: (A) inducing differentiation of pluripotent stem cells into definitive endoderm cells; and (B) culturing the definitive endoderm cells in the presence of (2?Z,3?E)-6-bromoindirubin-3?-oxime (BIO) and N-[(3,5-difluorophenyl)acetyl]-L-Ala-2-phenyl-L-Gly-tert-butyl-OH (DAPT) to thereby induce differentiation of the definitive endoderm cells into intestinal cells.
    Type: Application
    Filed: October 31, 2011
    Publication date: July 17, 2014
    Applicant: LSIP, LLC
    Inventors: Shoen Kume, Soichiro Ogaki, Nobuaki Shiraki, Kazuhiko Kume
  • Publication number: 20130252335
    Abstract: The purpose of the present invention is to provide a method and a culture medium which are capable of efficiently inducing the differentiation of pluripotent stem cells such as ES cells and iPS cells into desired cells by a simple means. The differentiation of pluripotent stem cells can be induced by culturing mammal-derived pluripotent stem cells in a differentiation culture medium that does not contain at least one amino acid selected from the group consisting of methionine, leucine, cysteine, tyrosine and arginine. Also provided is a differentiation-inducing culture medium which does not contain at least one amino acid selected from the group consisting of methionine, leucine, cysteine, tyrosine and arginine.
    Type: Application
    Filed: October 20, 2011
    Publication date: September 26, 2013
    Inventors: Shoen Kume, Fumio Endo, Nobuaki Shiraki, Yasuko Shiraki, Kazuhiko Kume
  • Patent number: 8309353
    Abstract: It is an object of the present invention to establish a system for reliably differentiating an ES cell into a hepatic cell. The present invention provides a method for inducing the differentiation of an ES cell into a hepatic cell, which comprises, in the presence of an M15 cell, culturing a mammal-derived ES cell in the presence of activin and bFGF, and then culturing the ES cell in the presence of dexamethasone, HGF, and oncostatin M.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: November 13, 2012
    Assignee: Kumamoto University
    Inventors: Shoen Kume, Nobuaki Shiraki, Kahoko Umeda, Kazuhiko Kume
  • Publication number: 20120058491
    Abstract: It is an object of the present invention to establish a system for reliably differentiating an ES cell into a hepatic cell. The present invention provides a method for inducing the differentiation of an ES cell into a hepatic cell, which comprises, in the presence of an M15 cell, culturing a mammal-derived ES cell in the presence of activin and bFGF, and then culturing the ES cell in the presence of dexamethasone, HGF, and oncostatin M.
    Type: Application
    Filed: May 30, 2008
    Publication date: March 8, 2012
    Applicant: KUMAMOTO UNIVERSITY
    Inventors: Shoen Kume, Nobuaki Shiraki, Kahoko Umeda, Kazuhiko Kume